ABF Associated British Foods plc
Associated British Foods plc engages in the food, ingredients, and retail businesses in the United Kingdom, Europe, the Americas, Africa, and the Asia Pacific. It operates through Retail, Grocery, and Ingredients segments. The Retail segment is involved in buying and merchandising clothing and accessories through the Primark and Penneys retail chains, which offer women's, men's, and kidswear, as well as beauty, homeware, and accessories. The Grocery segment offers hot beverages, sugar, vegetable oils, balsamic vinegars, bread and baked goods, cereals, international food and meat products to retail, wholesale, and foodservice businesses. The Ingredients segment manufactures yeast and bakery ingredients; specialty ingredients focused on enzymes, procession extracts, health and nutrition; and pharmaceutical delivery systems. The company was incorporated in 1934 and is headquartered in London, the United Kingdom. Associated British Foods plc operates as a subsidiary of Wittington Investments Limited.…
Industry Peers
Packaged FoodsKey Statistics
About Associated British Foods (LON: ABF)
›
Associated British Foods (LON: ABF) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 140,000 employees.
The shares were at 2020.00 GBp on 20 November 2026, down 8.8% over 52 weeks.
At a market capitalisation of 14.13B GBP, it trades at 15.3 times trailing earnings and 12.2 times forward earnings. The median trailing P/E of its 17 largest Packaged Foods peers is 25.2, a discount of 39% for ABF. It pays a dividend yielding 3.08% (it pays out 48% of its earnings), against a median of 3.91% among the dividend payers in that peer group.
Associated British Foods reports an operating margin of 7.4% and revenue up 1.6% year over year.
Its debt exceeds its cash by 2.84B GBP, a debt-to-equity ratio of 0.33. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 18 analysts cover the stock, with an average rating of Underperform; their mean price target of 1817.22 GBp is 10.0% below the current price. The next earnings report is expected on 20 April 2027.